Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1983;16(Suppl 1):87S–88S. doi: 10.1111/j.1365-2125.1983.tb02276.x

Midazolam and sleep in insomniac patients

J M Monti, J Debellis, P Alterwain, L D'Angelo
PMCID: PMC1428081  PMID: 6138087

Abstract

1 The effects of midazolam (15 and 30 mg p.o.) on the sleep of insomniac patients were assessed by means of polysomnographic recordings.

2 As compared with placebo, 15 mg midazolam significantly increased non-REM sleep while other objective measures of insomnia were only slightly modified.

3 At the 30 mg dose, midazolam significantly decreased total wake time and wake time after sleep onset. On the other hand, total sleep and non-REM sleep time were increased.

4 No development of tolerance was observed following 2 weeks of drug use.

Full text

PDF
87S

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Monti J. M., Debellis J., Gratadoux E., Alterwain P., Altier H., D'Angelo L. Sleep laboratory study of the effects of midazolam in insomniac patients. Eur J Clin Pharmacol. 1982;21(6):479–484. doi: 10.1007/BF00542042. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES